Predictive value of ALBI score and age for developing resistance to trastuzumab in HER-2-positive breast cancer patients: prediction based on a real-world case series from a single center in China. [PDF]
Front PharmacolLong J, Qin Y, Qi K, Li J.
europepmc +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Background The growing burden of cancer necessitates continuity of care interventions linking hospital and primary health care (PHC). However, optimal approaches for improving effectiveness and for enhancing care coordination of PHC integration remain unclear. Methods A systematic review with meta‐analysis was conducted.
Jiawei Geng +5 more
wiley +1 more source
Risk Factors of Trastuzumab Induced Cardiotoxicity in Her2-Positive Early Breast Cancer [PDF]
, 2014 Mehmet Alı Nahıt Şendur +9 more
openalex +1 more source
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting [PDF]
, 2020 Therse Björkin Joona +7 more
openalex +1 more source
Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates. [PDF]
World J OncolZheng ZN, Ye XH, Shen XB, Li T, Guo J.
europepmc +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Purpose Findings from our previous study showed that the combination of pyrotinib, trastuzumab, and chemotherapy represents a viable treatment strategy with an acceptable safety profile for heavily pre‐treated human epidermal growth factor receptor 2 (HER2)‐positive metastatic breast cancer (MBC).
Xiaofeng Xie +10 more
wiley +1 more source
Surgical treatment of stage IV gallbladder cancer after complete radiological, metabolic and biochemical response with chemotherapy and Trastuzumab [PDF]
, 2019 Mikel Prieto +7 more
openalex +1 more source
Site-Specific Glycan Conjugation Improves Stability and Efficacy of an Antibody-Drug Conjugates Bearing DXd as a Cytotoxic Payload. [PDF]
ACS OmegaManabe S +10 more
europepmc +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Background and Aims Microsatellite instability (MSI), programmed death‐ligand 1 (PD‐L1) expression, and Epstein–Barr virus (EBV) positivity are emerging biomarkers in gastric cancer prognosis and treatment selection, particularly in immunotherapy. This review evaluates their prognostic significance through a systematic review and meta‐analysis.
Fausto Petrelli +11 more
wiley +1 more source